SPL 2.06% 9.5¢ starpharma holdings limited

Has the seling dried up, page-56

  1. 9,210 Posts.
    lightbulb Created with Sketch. 820
    That wasn't the point . It was about trial structure and points of measurement in trial and how the virus has mutated . These mutations have created different time to onset to symptoms, different viral load at different times in progression of disease.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.